Understanding a severe form of lung transplant rejection
Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation
This study is looking into restrictive allograft syndrome (RAS), a serious issue that can happen after lung transplants, to understand how certain immune cells and antibodies cause rejection, with the hope of finding better treatments to help lung transplant patients live longer and healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10749064 on NIH RePORTER |
What this research studies
This research investigates restrictive allograft syndrome (RAS), a serious condition that can occur after lung transplantation, leading to poor patient outcomes. The study aims to uncover the mechanisms behind RAS by examining the role of specific immune cells and antibodies in the rejection process. Using a mouse model that mimics human RAS, researchers will analyze how activated B cells and other immune components contribute to this aggressive form of rejection. The findings could help identify new therapeutic strategies to improve survival rates for lung transplant recipients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have undergone lung transplantation and are at risk for or experiencing restrictive allograft syndrome.
Not a fit: Patients who have not received a lung transplant or those with other forms of transplant rejection unrelated to RAS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatments for patients experiencing severe lung transplant rejection, potentially improving their survival rates.
How similar studies have performed: Previous research has shown promising results in understanding immune responses in transplant rejection, suggesting that this approach may yield valuable insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Lama, Vibha N — Emory University
- Study coordinator: Lama, Vibha N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.